According to a report announced today at the ICUS Bubble Conference in Chicago.

Stephanie Wilson, MD, Professor of Radiology, University of Calgary, Section of Diagnostic Imaging, Foothills Medical Center, Calgary, Canada. Wilson spoke at the 25th annual Advances in Contrast Ultrasound conference. Wilson called CEUS an ideal tool for monitoring disease activity and response to therapy over a patient’s lifetime, and said it is particularly very important to young sufferers with lifelong IBD. She added that one expensive treatment options might be avoided when CEUS indicates that IBD isn’t active. Related StoriesSonaCare Medical's Sonablate 450 focused ultrasound program receives FDA authorization for ablation of prostate tissueResearchers perform initial focused ultrasound remedies in the U.S.today announced the industrial start of HYLENEX recombinant for make use of in pediatric rehydration at this year’s 2009 American University of Emergency Doctors scientific assembly . HYLENEX, an enzyme, enables liquids to be administered beneath the skin instead of through a vein. This enables for quick treatment initiation and delivery of intravenous -like fluid rates, that may help result in successful rehydration of kids in a much less invasive way. The scholarly research was made to assess the efficacy, safety and medical utility of HYLENEX recombinant-facilitated subcutaneous rehydration in gentle to moderately dehydrated kids ages 8 weeks to 10 years.